|
The VEGF Trap Eye extension data released last week was very impressive.
If this data is confirmed in phase 3, VEGF Trap Eye will be superior to Lucentis/Avastin in terms of a more durable response for wet AMD. I would not minimize this potential winner. Rating :
 (1 Rating) |
Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.25